The study compared the use of 4 mg to 5 mg and 8 mg to 10 mg intravenous doses. A total of 6,696 subjects were a part of 60 randomized clinical trials.
Results showed a similar effect with the 4 to 5 mg dose as the 8 to 10 mg dose, which supports using the lower dosage to get the same antiemetic properties.
More Articles on Anesthesia:
7 Priorities for Anesthesiologists & ASCs in 2013
Stalled Political Efforts Could Bring 27% SGR Cut
Study: Gene Could be Responsible for Sepsis Predisposition
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
